Public Employees Retirement Association of Colorado Sells 298 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Public Employees Retirement Association of Colorado trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,427 shares of the biotechnology company’s stock after selling 298 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Axon Enterprise were worth $2,185,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its stake in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the period. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise in the 4th quarter worth about $26,000. Trivant Custom Portfolio Group LLC bought a new stake in Axon Enterprise during the 1st quarter valued at about $31,000. First PREMIER Bank purchased a new stake in Axon Enterprise in the 1st quarter valued at about $33,000. Finally, Rise Advisors LLC grew its stake in Axon Enterprise by 49.0% in the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock worth $45,000 after acquiring an additional 47 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on AXON shares. Northland Securities lifted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Barclays lifted their target price on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Bank of America initiated coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Finally, Craig Hallum increased their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Axon Enterprise Stock Up 0.2 %

Shares of AXON stock opened at $393.94 on Tuesday. The stock’s fifty day moving average price is $349.75 and its 200 day moving average price is $317.79. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $397.32. The company has a market cap of $29.73 billion, a price-to-earnings ratio of 115.19, a price-to-earnings-growth ratio of 10.34 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company’s revenue was up 34.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.80 earnings per share. On average, research analysts expect that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the sale, the director now directly owns 27,259 shares of the company’s stock, valued at $10,385,406.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $380.99, for a total transaction of $380,990.00. Following the completion of the transaction, the director now owns 27,259 shares in the company, valued at approximately $10,385,406.41. The disclosure for this sale can be found here. Over the last quarter, insiders sold 317,981 shares of company stock valued at $115,662,734. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.